Allergan PLC (AGN)

Common-Size Statement of Financial Position, Liabilities and Stockholders' Equity

Difficulty: Beginner

Annual Data

Quarterly Data

Allergan PLC, Common-Size Consolidated Statement of Financial Position, Liabilities and Stockholders' Equity

	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013
Accrued third-party rebates
Contractual commitments, including amount due to Teva
Accrued payroll and related benefits
Accrued returns
Interest payable
Royalties payable
Accrued pharmaceutical fees
Accrued R&D expenditures
Accrued severance, retention and other shutdown costs
Litigation-related reserves and legal fees
Accrued non-provision taxes
Current portion of contingent consideration obligations
Accrued selling and marketing expenditures
Dividends payable
Other accrued expenses
Accrued expenses	%	%	%	%	%
Accounts payable
Accounts payable and accrued expenses	%	%	%	%	%
Income taxes payable
Current portion of long-term debt and capital leases
Deferred revenue
Current liabilities held for sale
Deferred tax liabilities
Current liabilities	%	%	%	%	%
Long-term debt and capital leases, excluding current portion
Acquisition related contingent consideration liabilities
Long-term pension and post retirement liability
Legacy Allergan deferred executive compensation
Long-term severance and restructuring liabilities
Deferred revenue
Product warranties
Long-term contractual obligations
Litigation-related reserves
Other long-term liabilities
Other long-term liabilities	%	%	%	%	%
Long-term liabilities held for sale
Other taxes payable
Deferred tax liabilities
Non current liabilities	%	%	%	%	%
Total liabilities	%	%	%	%	%
Preferred shares, $0.0001 par value per share
Ordinary shares; $0.0001 par value per share
Additional paid-in capital
Retained earnings (accumulated deficit)
Accumulated other comprehensive income (loss)
Treasury stock, at cost
Shareholders' equity	%	%	%	%	%
Noncontrolling interest
Total equity	%	%	%	%	%
Total liabilities and equity	%	%	%	%	%

	Allergan PLC	Other companies (not purchased previously)
Financial Statements
Common-Size Financial Statements
Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis
Financial Reporting Quality

	All companies
Financial Statements
Common-Size Financial Statements
Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis
Financial Reporting Quality